The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure
- PMID: 19782786
- PMCID: PMC2762950
- DOI: 10.1016/j.ahj.2009.07.016
The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure
Abstract
Background: Cardiopulmonary exercise testing (CPX) in patients with systolic heart failure (HF) is important for determining HF prognosis and helping guide timing of heart transplantation. Although approximately 20% to 30% of patients with HF are obese (body mass index [BMI] >30 kg/m(2)), the impact of BMI on CPX results is not well established. The objective of this study was to assess the relationship between BMI and CPX variables, including peak oxygen uptake (VO(2)) at ventilatory threshold, oxygen pulse, and ventilation-carbon dioxide production ratio.
Methods: Consecutive patients with systolic HF (n = 2,324) enrolled in the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training trial who had baseline BMI recorded were included in this study. Subjects were divided into strata based on BMI: underweight (BMI <18.5 kg/m(2)), normal weight (BMI 18.5-24.9 kg/m(2)), overweight (BMI 25.0-29.9 kg/m(2)), obese I (BMI 30-34.9 kg/m(2)), obese II (BMI 35-39.9 kg/m(2)), and obese III (BMI > or = 40 kg/m(2)).
Results: Obese III, but not overweight; obese I; or obese II was associated with decreased peak VO(2) (mL kg(-1) min(-1)) compared to normal weight status. Increasing BMI category was inversely related to ventilation/carbon dioxide production (V(E)/V(CO2)) ratio (P < .0001). On multivariable analysis, BMI was a significant independent predictor of peak VO(2) (partial R(2) = 0.07, P < .0001) and V(E)/V(CO2) slope (partial R(2) = 0.03, P < .0001) in patients with chronic systolic HF.
Conclusions: Body mass index is significantly associated with key CPX fitness variables in patients with HF. The influence of BMI on the prognostic value of CPX in HF requires further evaluation in longitudinal studies.
Trial registration: ClinicalTrials.gov NCT00047437.
Figures



References
-
- Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y for the American Heart Association Statistics Committee and Stroke Statistics S. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146. - PubMed
-
- Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987;59:634–638. - PubMed
-
- Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778–786. - PubMed
-
- Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation. 2004;110:e27–e31. - PubMed
-
- Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part I: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. Eur J Cardiovasc Prev Rehabil. 2006;13:150–164. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 HL066491/HL/NHLBI NIH HHS/United States
- HL068973/HL/NHLBI NIH HHS/United States
- R37 AG018915/AG/NIA NIH HHS/United States
- U01 HL066494/HL/NHLBI NIH HHS/United States
- HL068980/HL/NHLBI NIH HHS/United States
- U01 HL064264/HL/NHLBI NIH HHS/United States
- HL064257/HL/NHLBI NIH HHS/United States
- HL066491/HL/NHLBI NIH HHS/United States
- U01 HL068980/HL/NHLBI NIH HHS/United States
- P30 AG021332/AG/NIA NIH HHS/United States
- HL064265/HL/NHLBI NIH HHS/United States
- U01 HL064257/HL/NHLBI NIH HHS/United States
- 5U01-HL066461/HL/NHLBI NIH HHS/United States
- U01 HL066482/HL/NHLBI NIH HHS/United States
- U01 HL064250/HL/NHLBI NIH HHS/United States
- 5U01-HL063747/HL/NHLBI NIH HHS/United States
- HL066497/HL/NHLBI NIH HHS/United States
- HL066501/HL/NHLBI NIH HHS/United States
- R01 AG018915/AG/NIA NIH HHS/United States
- HL064250/HL/NHLBI NIH HHS/United States
- HL066494/HL/NHLBI NIH HHS/United States
- U01 HL064265/HL/NHLBI NIH HHS/United States
- HL064264/HL/NHLBI NIH HHS/United States
- U01 HL066461/HL/NHLBI NIH HHS/United States
- U01 HL068973/HL/NHLBI NIH HHS/United States
- U01 HL063747/HL/NHLBI NIH HHS/United States
- HL066482/HL/NHLBI NIH HHS/United States
- U01 HL066501/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous